3Rupprecht CE,Hanlon CA,Slate D.Oral immunization of wildlife against rabies:opportunities and challenges in prevention and control[J].Dev Biol(Basel),2004,119:173-184.
4Grosenbaugh DA,Maki JL,Rupprecht CE,et al.Rabies challenge of captivetive striped skunks (Mephitis mephitits) following oral administration of a live vaccinia-vectored rabies vaccine[J].J Wildl Dis,2007,43(1):124-128.
5Rupprecht CE,Hanlon CA,Blanton J,et al.Oral vaccination of dogs with recombinant rabies virus vaccines.[J].Virus Res,2005,111(1):101-105.
6Jacobs BL,Langland JO,Kibler KV,et al.Vaccinia virus vaccines:past,present and future[J].Antiviral Res,2009,84(1):1-13.
7Weyer J,Rupprecht CE,Nel LH.Poxvirus-vectored vaccines for rabies-A review[J].Vaccine,2009,27(51):7198-7201.
8Rupprecht CE,Blass L,Smith K,et al.Human infection due to recombinant vaccinia-rabies glycoprotein virus[J].N Engl J Med,2001,345(8):582-586.
9Pastoret PP,Vanderplasschen A.Poxviruses as vaccine vectors[J].Comp Immunol Microbiol Infect Dis,2003,26(5-6):343-355.
10Grosenbaugh DA,Leard T,Pardo MC.Protection from challenge following administration of canarypox virus-vectored recombinant feline leukaemia virus vaccine in cats previously vaccinated with a killed virus vaccine[J].J Am Vet Med Assoc,2006,228(5):726-727.
